Hasil Pencarian (1)
biotech | CAS: 1803171-55-2
Ravulizumab is a potent and selective complement 5 (C5) inhibitor. It is a humanized monoclonal IgG2/4 kappa antibody produced in Chinese hamster ovary (CHO) cells.[L39690] Ravulizumab was engineered from [eculizumab], another complement inhibitor, to increas…
Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal
+15
Target Protein:
Complement C5
Waktu ParuhThe mean (%CV) term…
Vol. DistribusiThe mean (%CV) volu…
KlirensThe mean (%CV) clea…
Genetik
-